184 related articles for article (PubMed ID: 22804687)
1. The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.
Grunewald TG; Bach H; Cossarizza A; Matsumoto I
Biol Cell; 2012 Nov; 104(11):641-57. PubMed ID: 22804687
[TBL] [Abstract][Full Text] [Related]
2. STEAP proteins: from structure to applications in cancer therapy.
Gomes IM; Maia CJ; Santos CR
Mol Cancer Res; 2012 May; 10(5):573-87. PubMed ID: 22522456
[TBL] [Abstract][Full Text] [Related]
3. Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer.
Azumi M; Kobayashi H; Aoki N; Sato K; Kimura S; Kakizaki H; Tateno M
J Urol; 2010 May; 183(5):2036-44. PubMed ID: 20303532
[TBL] [Abstract][Full Text] [Related]
4. STEAP1 is overexpressed in cancers: a promising therapeutic target.
Moreaux J; Kassambara A; Hose D; Klein B
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):148-55. PubMed ID: 23142226
[TBL] [Abstract][Full Text] [Related]
5. STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer.
Xu M; Evans L; Bizzaro CL; Quaglia F; Verrillo CE; Li L; Stieglmaier J; Schiewer MJ; Languino LR; Kelly WK
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011027
[TBL] [Abstract][Full Text] [Related]
6. Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer.
Hayashi S; Kumai T; Matsuda Y; Aoki N; Sato K; Kimura S; Kitada M; Tateno M; Celis E; Kobayashi H
J Transl Med; 2011 Nov; 9():191. PubMed ID: 22053850
[TBL] [Abstract][Full Text] [Related]
7. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.
Kobayashi H; Nagato T; Sato K; Aoki N; Kimura S; Murakami M; Iizuka H; Azumi M; Kakizaki H; Tateno M; Celis E
Cancer Res; 2007 Jun; 67(11):5498-504. PubMed ID: 17545632
[TBL] [Abstract][Full Text] [Related]
8. Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes.
Rodeberg DA; Nuss RA; Elsawa SF; Celis E
Clin Cancer Res; 2005 Jun; 11(12):4545-52. PubMed ID: 15958640
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Intercellular Communication between Prostate Cancer Cells by A Specific Anti-STEAP-1 Single Chain Antibody.
Esmaeili SA; Nejatollahi F; Sahebkar A
Anticancer Agents Med Chem; 2018; 18(12):1674-1679. PubMed ID: 29219059
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a single b-type heme, FAD, and metal binding sites in the transmembrane domain of six-transmembrane epithelial antigen of the prostate (STEAP) family proteins.
Kleven MD; Dlakić M; Lawrence CM
J Biol Chem; 2015 Sep; 290(37):22558-69. PubMed ID: 26205815
[TBL] [Abstract][Full Text] [Related]
11. Six-transmembrane epithelial antigen of the prostate-1 plays a role for in vivo tumor growth via intercellular communication.
Yamamoto T; Tamura Y; Kobayashi J; Kamiguchi K; Hirohashi Y; Miyazaki A; Torigoe T; Asanuma H; Hiratsuka H; Sato N
Exp Cell Res; 2013 Oct; 319(17):2617-26. PubMed ID: 23916873
[TBL] [Abstract][Full Text] [Related]
12. Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1).
Oosterheert W; Gros P
J Biol Chem; 2020 Jul; 295(28):9502-9512. PubMed ID: 32409586
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.
Challita-Eid PM; Morrison K; Etessami S; An Z; Morrison KJ; Perez-Villar JJ; Raitano AB; Jia XC; Gudas JM; Kanner SB; Jakobovits A
Cancer Res; 2007 Jun; 67(12):5798-805. PubMed ID: 17575147
[TBL] [Abstract][Full Text] [Related]
14. The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer.
Wu HT; Chen WJ; Xu Y; Shen JX; Chen WT; Liu J
Biomed Res Int; 2020; 2020():9578484. PubMed ID: 32802887
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2.
Chen K; Wang L; Shen J; Tsai AL; Zhou M; Wu G
Elife; 2023 Nov; 12():. PubMed ID: 37983176
[TBL] [Abstract][Full Text] [Related]
16. Predictive potential of STEAP family for survival, immune microenvironment and therapy response in glioma.
Zhao Z; Wang Z; Song Z; Wu Y; Jin Q; Zhao Z
Int Immunopharmacol; 2021 Dec; 101(Pt A):108183. PubMed ID: 34649092
[TBL] [Abstract][Full Text] [Related]
17. Membrane cholesterol modulates STEAP2 conformation during dynamic intracellular trafficking processes leading to broad subcellular distribution.
Hasegawa H; Li C; Alba BM; Penny DM; Xia Z; Dayao MR; Li P; Zhang J; Zhou J; Lim D; Murawsky CM; Lim AC
Exp Cell Res; 2018 Sep; 370(2):208-226. PubMed ID: 29940176
[TBL] [Abstract][Full Text] [Related]
18. The Steap proteins are metalloreductases.
Ohgami RS; Campagna DR; McDonald A; Fleming MD
Blood; 2006 Aug; 108(4):1388-94. PubMed ID: 16609065
[TBL] [Abstract][Full Text] [Related]
19. Steap proteins: implications for iron and copper metabolism.
Knutson MD
Nutr Rev; 2007 Jul; 65(7):335-40. PubMed ID: 17695374
[TBL] [Abstract][Full Text] [Related]
20. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
